P-9.0001, r. 1 - Regulation respecting access authorizations and the duration of use of information held in a health information bank in a clinical domain

Full text
chapter P-9.0001, r. 1
Regulation respecting access authorizations and the duration of use of information held in a health information bank in a clinical domain
SHARING OF CERTAIN HEALTH INFORMATION — ACCESS AUTHORIZATIONS — INFORMATION BANK
Act respecting the sharing of certain health information
(chapter P-9.0001, ss. 70, 72, 110 and 121).
P-9.0001
June 20 2013
DIVISION 0.1
OTHER PERSONS WHO MAY BE ACCESS AUTHORIZATION MANAGERS
2018-016M.O. 2018-016, s. 1.
0.1. In addition to what is provided in section 65 of the Act, a person operating a pharmacist placement agency and who has a supervisory or managerial power towards pharmacists who have a status of employee of that agency may be an access authorization manager.
For the purposes of this Regulation, pharmacist placement agency means an enterprise whose activities consist in providing pharmacist placement or temporary help services to pharmacies the owner of which is a pharmacist subject to the application of an agreement described in section 19 of the Health Insurance Act (chapter A-29).
2018-016M.O. 2018-016, s. 1.
DIVISION I
ACCESS AUTHORIZATIONS THAT MAY BE ASSIGNED TO A PROVIDER
1. Access authorizations may be assigned to a physician referred to in paragraph 1 or 2 of section 69 of the Act respecting the sharing of certain health information (chapter P-9.0001) to enable the physician to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain;
(4)  the hospitalization domain.
Access authorizations may also be assigned to such a provider to enable the provider to
(1)  release any electronic prescription for medication written by that provider to the operations manager of the electronic prescription management system for medication; and
(2)  receive such information of prescriptions held in that system.
The same access authorizations may be assigned to the holder of a training card, issued by the secretary of the Collège des médecins du Québec, referred to in paragraph 9 of section 69 of the Act or the holder of an authorization, issued by the Collège des médecins du Québec under section 42.4 of the Professional Code (chapter C-26), referred to in paragraph 10 of section 69 of the Act.
M.O. 2013-03, s. 1; 2018-016M.O. 2018-016, s. 2.
2. Access authorizations may be assigned to a pharmacist referred to in paragraph 3 or 4 of section 69 of the Act to enable the pharmacist to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain;
(4)  the hospitalization domain.
Access authorizations may also be assigned to such a provider to enable the provider to
(1)  release any electronic prescription for medication written by that provider to the operations manager of the electronic prescription management system for medication;
(2)  receive such information of prescriptions held in that system; and
(3)  retrieve prescriptions held in that system.
The same access authorizations may be assigned to a pharmacy resident or a pharmacy intern referred to in paragraph 11 or 12 of section 69 of the Act.
M.O. 2013-03, s. 2; 2018-016M.O. 2018-016, s. 3.
3. Access authorizations may be assigned to a nurse referred to in paragraph 5 of section 69 of the Act to enable the nurse to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain.
Access authorizations may be assigned to such a provider with the legal authority to prescribe medications to enable the provider to
(1)  release any electronic prescription for medication written by that provider to the operations manager of the electronic prescription management system for medication; and
(2)  receive such information of prescriptions held in that system.
M.O. 2013-03, s. 3.
4. Access authorizations may be assigned to a nursing assistant referred to in paragraph 6 of section 69 of the Act to enable the nursing assistant to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain.
M.O. 2013-03, s. 4.
5. Access authorizations may be assigned to a midwife referred to in paragraph 7 of section 69 of the Act to enable the midwife to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain.
Access authorizations may also be assigned to such a provider to enable the provider to
(1)  release any electronic prescription for medication written by that provider to the operations manager of the electronic prescription management system for medication; and
(2)  receive such information of prescriptions held in that system.
M.O. 2013-03, s. 5.
6. Access authorizations may be assigned to a biochemist or microbiologist referred to in paragraph 8 of section 69 of the Act to enable the biochemist or microbiologist to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain.
M.O. 2013-03, s. 6.
7. Access authorizations may be assigned to a person providing technical support services to a physician and referred to in paragraph 13 of section 69 of the Act to enable the person to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain.
M.O. 2013-03, s. 7.
8. Access authorizations may be assigned to a person providing technical support services to a pharmacist and referred to in paragraph 14 of section 69 of the Act to enable the person to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain.
Access authorizations may also be assigned to such a provider to enable the provider to
(1)  receive information of prescriptions held in the electronic prescription management system for medication; and
(2)  retrieve prescriptions held in that system.
M.O. 2013-03, s. 8.
9. Access authorizations may be assigned to a medical archivist referred to in paragraph 15 of section 69 of the Act to enable the medical archivist to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain.
M.O. 2013-03, s. 9.
9.1. An inspector, an investigator or a syndic referred to in section 192 of the Professional Code (chapter C-26) acting for the Collège des médecins du Québec or for the Ordre des pharmaciens du Québec may be assigned access authorizations allowing them to receive health information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain;
(4)  the hospitalization domain.
Such a provider may also be assigned access authorizations allowing the provider to receive information of prescriptions held in the electronic prescription management system for medication.
2018-016M.O. 2018-016, s. 4.
10. The access authorizations that may be assigned to the providers referred to in this Division are so assigned in accordance with the terms and conditions provided for in the Act.
M.O. 2013-03, s. 10.
DIVISION II
ACCESS AUTHORIZATIONS THAT MAY BE ASSIGNED TO A BODY
11. Access authorizations may be assigned to an institution governed by the Act respecting health services and social services (chapter S-4.2) to enable the body to release information to the operations manager of a health information bank in the following clinical domains:
(1)  the medication domain, provided that the institution operates a centre where a pharmacist practises;
(2)  the laboratory domain, provided that the institution operates a medical biology laboratory or requests that a laboratory analysis be produced by the laboratory of Héma-Québec, the laboratory of the Centre de toxicologie du Québec or the Laboratoire de santé publique du Québec;
(3)  the medical imaging domain, provided that the institution operates a centre in which a clinical medical imaging department is set up;
(4)  the hospitalization domain, provided that the institution operates a hospital centre.
Access authorizations may be assigned to such a body to enable the body to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain;
(4)  the hospitalization domain.
Such access authorizations may be assigned to the Cree Board of Health and Social Services of James Bay established under the Act respecting health services and social services for Cree Native persons (chapter S-5), on the same conditions.
M.O. 2013-03, s. 11; S.Q. 2017, c. 21, s. 97; 2018-016M.O. 2018-016, s. 5.
12. Access authorizations may be assigned to persons or partnerships operating a community pharmacy to enable them to release information to the operations manager of a health information bank in the medication domain.
Access authorizations may be assigned to such a body to enable the body to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain;
(4)  the hospitalization domain.
M.O. 2013-03, s. 12; 2018-016M.O. 2018-016, s. 6.
13. Access authorizations may be assigned to persons or partnerships operating a medical biology laboratory, within the meaning of the Regulation respecting the application of the Act respecting medical laboratories and organ and tissue conservation (chapter L-0.2, r. 1), to enable them to release information to the operations manager of a health information bank in the laboratory domain.
M.O. 2013-03, s. 13.
14. Access authorizations may be assigned to persons or partnerships operating a medical imaging laboratory or a medical diagnostic radiology laboratory, within the meaning, respectively, of the Act respecting medical laboratories and organ and tissue conservation (chapter L-0.2) and the Regulation respecting the application of the Act respecting medical laboratories and organ and tissue conservation (chapter L-0.2, r. 1), to enable them to release information to the operations manager of a health information bank in the medical imaging domain.
M.O. 2013-03, s. 14.
15. Access authorizations may be assigned to persons or partnerships operating a private physician’s office or a specialized medical centre referred to in section 333.1 of the Act respecting health services and social services (chapter S-4.2) to enable them to receive information held in the health information banks in the following clinical domains:
(1)  the medication domain;
(2)  the laboratory domain;
(3)  the medical imaging domain;
(4)  the hospitalization domain.
M.O. 2013-03, s. 15; 2018-016M.O. 2018-016, s. 7.
16. (Revoked).
M.O. 2013-03, s. 16; S.Q. 2017, c. 21, s. 98; 2018-016M.O. 2018-016, s. 8.
17. Access authorizations may be assigned to a body to enable the body to receive information held in the health information banks in a clinical domain only if an authorized provider performs his or her duties within that domain.
M.O. 2013-03, s. 17.
18. Access authorizations that may be assigned to the bodies referred to in this Division are so assigned in accordance with the terms and conditions provided for in the Act.
M.O. 2013-03, s. 18.
DIVISION III
DURATION OF USE
19. Health information held in a health information bank in a clinical domain is used for a 7-year period from the time it is received by the operations manager of that information bank.
M.O. 2013-03, s. 19; 2018-016M.O. 2018-016, s. 9.
DIVISION IV
COMING INTO FORCE
20. (Omitted).
M.O. 2013-03, s. 20.
REFERENCES
M.O. 2013-03, 2013 G.O. 2, 1201
S.Q. 2017, c. 21, ss. 97 and 98
M.O. 2018-016, 2018 G.O. 2, 5035